US EditionCancer Patients Caught in Brexit Crossfire as Red Tape Delays Vital Treatments
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Cancer Patients Caught in Brexit Crossfire as Red Tape Delays Vital Treatments
On Europe Day, a leaked report has cast a grim shadow over the state of cancer care in the UK, with Brexit emerging as a key culprit in delaying access to vital treatments and cutting-edge drug trials. The report, which has triggered deep concern across Scotland and beyond, reveals that red tape and spiralling costs brought on by the UK’s exit from the EU are derailing progress in cancer care. Doctors are facing mounting barriers as they try to …
Brexit's effect on clinical trials - Cancer Research UK | Onco Daily - Brexit Carnage
Some 80% of British researchers say that since Brexit it has been difficult to collaborate closely and efficiently with EU based cancer researchers. Read More The post Brexit’s effect on clinical trials – Cancer Research UK | Onco Daily appeared first on Brexit Carnage.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
